Citations

Clear

14 citation(s) found for "Perry, James".

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Ajani, Jaffer A. , D’Amico, Thomas A., Bentrem, David J., Corvera, Carlos U. , Das, Prajnan , Denlinger, Crystal S. , Enzinger, Peter C. , Fanta, Paul T. , Farjah, Farhood , Gerdes, Hans, Glasgow, Robert E. , Hayman, James A. , Hochwald, Steven N. , Hofstetter, Wayne L. , Ilson, David H. , Jaroszewski, Dawn E. , Johung, Kimberly L. , Keswani, Rajesh N. , Kleinberg, Lawrence , Leong, Stephen , Ly, Quan P. , Matkowskyj, Kristina A. , McNamara, Michael J. , Mulcahy, Mary F. , Paluri, Ravi Kumar , Park, Haeseong , Poultsides, George A. , Roses, Robert E. , Strong, Vivian E. , Wiesner, Georgia L. , Willett, Christopher G. , Wright, Cameron D., McMillian, Nicole R., Pluchino, Lenora A. , Jaroszewski, Dawn, Ajani, Jaffer A , Bentrem, David J. , Chao, Joseph , Gibson, Michael K. , Perry, Kyle A. , Pimiento, José M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | July 18, 2019 | Volume: 17 | Issue: 7 | Pages: 855-883

10.6004/jnccn.2019.0033 | PMID 31319389 Get It

Abstract Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resectable esophageal and esophagogastric junction (EGJ) cancer, and randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival. Targeted therapies including trastuzumab, ramucirumab, and pembrolizumab have produced encouraging results in the treatment of patients with advanced or metastatic disease. Multidisciplinary team management is essential for all patients with esophageal and EGJ cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Updates in the management of intradural spinal cord tumors: a radiation oncology focus
Kotecha, Rupesh , Chang, Eric L. , Brown, Paul D. , Lo, Simon S. , Samawi, Haider , Keith, Julia , Perry, James , Sahgal, Arjun , Mehta, Minesh P. , Suh, John H. , Das, Sunit

Mayo Clinic

Neuro-Oncology | January 14, 2019 | Volume: 21 | Issue: 6 | Pages: 707-718

10.1093/neuonc/noz014 | PMID 30977511 Get It

Abstract Primary spinal cord tumors represent a hetereogeneous group of central nervous system malignancies whose management is complex given the relatively uncommon nature of the disease and variety of tumor subtypes, functional neurologic deficits from the tumor, and potential morbidities associated with definitive treatment. Advances in neuroimaging; integration of diagnostic, prognostic, and predictive molecular testing into tumor classification; and developments in neurosurgical techniques have refined the current role of radiotherapy in the multimodal management of patients with primary spinal cord tumors, and corroborated the need for prospective, multidisciplinary discussion and treatment decision making. Radiotherapeutic technological advances have dramatically improved the entire continuum from treatment planning to treatment delivery, and the development of stereotactic radiosurgery and proton radiotherapy provides new radiotherapy options for patients treated in the definitive, adjuvant, or salvage setting. The objective of this comprehensive review is to provide a contemporary overview of the management of primary intradural spinal cord tumors, with a focus on radiotherapy.
Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
Twohy, Erin , Meyers, Michael O. , Boffa, Daniel J., Mitchell, Kisha A. , Ilson, David H. , Goodman, Karyn A. , Hall, Nathan C. , Bekaii‐Saab, Tanios , Ou, Fang‐Shu , Perry, Kyle A. , Frankel, Wendy L. , Venook, Alan P. , O’Reilly, Eileen M.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4012-4012

10.1200/jco.2018.36.15_suppl.4012 Get It

COMPASS: A Novel Risk-Adjustment Model for Catheter Ablation in Pediatric and Congenital Heart Disease Patients
Triedman, John K. , Pfeiffer, Patricia, Berman, Adam E. , Blaufox, Andrew D., Cannon, Bryan C. , Fish, Frank A. , Pflaumer, Andreas , Seslar, Stephen P. , Taskforce, Pediatric and Congenital Electrophysiology Society (PACES) MAP-IT, Pfeiffer, Patricia, Perry, James C. , Taskforce, Pediatric and Congenital Electrophysiology Society (PACES) MAP-IT

Mayo Clinic

Congenital Heart Disease | March 14, 2013 | Volume: No volume available | Issue: No issue available | Pages: n/a-n/a

10.1111/chd.12050 | PMID 23489580 Get It